Harris Associates’s Zoetis ZTS Stock Holding History

Harris Associates’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,405	Closed	-$219K	–	188
2025 Q2	$219K	Buy	+1,405	New	+$223K	﹤0.01%	159

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Harris Associates's ZTS Position: Q3 2025 in Review

Harris Associates sold out of Zoetis (ZTS) in Q3 2025, closing a stake of 1,405 shares — an estimated $219K sold.

Harris Associates first reported a position in ZTS in Q2 2025 and held it in 1 quarter. The position peaked at $219K in Q2 2025. 1,799 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.

Harris Associates reported no remaining Zoetis position as of Q3 2025 after selling out during the quarter.
Harris Associates sold 1,405 Zoetis shares in Q3 2025, an estimated $219K.
Harris Associates first reported a position in Zoetis in Q2 2025 and held it in 1 quarter.
Harris Associates's Zoetis position peaked at $219K in Q2 2025.
1,799 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.

Based on Harris Associates's 13F filing for Q3 2025, filed 14 Nov 2025.